| Stereochemistry | ACHIRAL |
| Molecular Formula | C21H32N |
| Molecular Weight | 298.4855 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 1 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCC[N+]1=CC=C2C=CC=CC2=C1
InChI
InChIKey=ZFCMISKWVFUWHP-UHFFFAOYSA-N
InChI=1S/C21H32N/c1-2-3-4-5-6-7-8-9-10-13-17-22-18-16-20-14-11-12-15-21(20)19-22/h11-12,14-16,18-19H,2-10,13,17H2,1H3/q+1
| Molecular Formula | C21H32N |
| Molecular Weight | 298.4855 |
| Charge | 1 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Sourcing
Sample Use Guides
Decelerine (one of the components is Lauryl isoquinolium bromide) must be incorporated into the water phase. If the processing requires heating, it must be added at the final step of the manufacturing process. A dosage of 3% decelerine in final formulation is recommended.
Route of Administration:
Topical
